Login

GI Partners Acquires GSK Global Vaccine Centre in $337.5 Million Deal

San Francisco Equity Fund Adds GlaxoSmithKline's Rockville Vaccine Research and Development Campus to Holdings
By Sean Freeman
January 9, 2017 | 6:37 P.M.

San Francisco-based GI Partners secured a significant East Coast investment with its purchase of the GSK Global Vaccine Centre in Rockville, MD from BioMed Realty for $337.5 million, or approximately $513 per square foot.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE


  • Properties